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OBJECTIVES To assess the contribution of expiratory flow limitation (FL) in orthopnea during acute left
heart failure (LHF).
BACKGROUND Orthopnea is typical of acute LHF, but its mechanisms are not completely understood. In
other settings, such as chronic obstructive pulmonary disease, dyspnea correlates best with
expiratory FL and can, therefore, be interpreted as, in part, the result of a hyperinflation-
related increased load to the inspiratory muscles. As airway obstruction is common in acute
LHF, postural FL could contribute to orthopnea.
METHODS Flow limitation was assessed during quiet breathing by applying a negative pressure at the
mouth throughout tidal expiration (negative expiratory pressure [NEP]). Flow limitation was
assumed when expiratory flow did not increase during NEP. Twelve patients with acute LHF
aged 40–98 years were studied seated and supine and compared with 10 age-matched healthy
subjects.
RESULTS Compared with controls, patients had rapid shallow breathing with slightly increased minute
ventilation and mean inspiratory flow. Breathing pattern was not influenced by posture. Flow
limitation was observed in four patients when seated and in nine patients when supine. In
seven cases, FL was induced or aggravated by the supine position. This coincided with
orthopnea in six cases. Only one out of the five patients without orthopnea had posture
dependent FL. Control subjects did not exhibit FL in either position.
CONCLUSIONS Expiratory FL appears to be common in patients with acute LHF, particularly so when
orthopnea is present. Its postural aggravation could contribute to LHF-related orthopnea.
(J Am Coll Cardiol 2000;35:690–700) © 2000 by the American College of Cardiology
Orthopnea is a clinical hallmark of left heart failure (LHF),
but its mechanisms are poorly understood (1). Orthopnea is
also present in various respiratory disorders, for example
asthma or chronic obstructive pulmonary disease (COPD).
These diseases are characterized by airway obstruction,
defined as a reduction in expiratory flow rates. As the
disease progresses, the maximal expiratory flow-volume
curve becomes increasingly convex toward the volume axis
(Fig. 1). When the reduction of expiratory flow rates is
sufficiently severe, flow limitation (FL) may occur during
tidal breathing, i.e., tidal exhalation lies on or above the
forced expiratory flow-volume relationship (2–5, Fig. 1).
Flow limitation hinders lung emptying and leads to dynamic
hyperinflation, a situation where the end-expiratory lung
volume exceeds the elastic equilibrium or relaxation volume
of the respiratory system. At this volume, alveolar pressure
is equal to atmospheric pressure. With dynamic hyperinfla-
tion, the persistent elastic recoil force present at the end of
expiration exerts a positive end-expiratory alveolar pressure
(intrinsic positive end-expiratory pressure). This pressure
must be overcome by the inspiratory muscles before they can
generate gas flow toward the alveoli; hence, it represents an
inspiratory elastic threshold load. Hyperinflation thus in-
creases the burden on the respiratory muscles by increasing
the elastic component of the work of breathing, while the
concomitant changes in rib cage geometry put the inspira-
tory muscles at a mechanical disadvantage (6). This is
considered to be a major source of dyspnea. In a recent study
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of 117 COPD patients (4), FL was the respiratory mechan-
ical parameter that correlated best with dyspnea.
Airway obstruction can occur during LHF through var-
ious mechanisms and with various degrees of severity (7).
Indeed, acute LHF can mimic acute asthma, a circumstance
commonly referred to as “cardiac asthma.” Pulmonary func-
tion studies have demonstrated increased airway resistance
or decreased forced expiratory flows in LHF (8). The rapid
increase in left end-diastolic pressure observed during angi-
nal syndrome is accompanied by a fall in lung compliance
and an increase in airway resistance (9). The existence of
dysfunction in small airways in LHF is suggested by an
increased closing volume (10) and the development of an
abnormal frequency dependence of total pulmonary resis-
tance (11). Studies of respiratory system impedance with the
forced oscillation technique have shown that pulmonary
congestion is consistently associated with an abnormal
frequency dependence of resistance at low frequencies (12)
and have suggested that with severe left ventricular failure
there is a significant narrowing of the large airways (12).
Finally, some patients with LHF, when challenged with
methacholine, exhibit nonspecific bronchial hyperrespon-
siveness (13).
Based on recent advances in the understanding of dys-
pnea in COPD, this study was carried out to examine the
possible role of FL in the pathogenesis of LHF-related
orthopnea. For this purpose, expiratory FL was assessed in
the sitting and the supine position with the recently intro-
duced “NEP” (negative expiratory pressure) technique (14)
in a population of patients with severe acute LHF and in an
age-matched control group. The NEP technique can detect
FL during tidal breathing without the need for subject
cooperation (5).
Patients and controls. All patients admitted over a period
of eight months to the Intensive Care Units of the Depart-
ments of Pneumology and Cardiology of our hospital with
presumed severe acute LHF were screened for inclusion.
Inclusion criteria included features compatible with LHF on
clinical history, clinical examination, chest X-ray [pulmo-
nary edema was quantitated according to the score proposed
by Milne and Pistolesi (48).], blood gas analysis and
echocardiographic assessment of left heart function (Table
1). Patients were not included if they were heavy smokers or
past smokers (cumulative tobacco consumption above
15 pack-years or tobacco cessation for less than 20 years),
had a history of chronic respiratory disease or if clinical
examination (14), chest X-ray or blood gases were indicative
of COPD. The need for mechanical ventilation was not an
exclusion criteria if the patient could be studied while
spontaneously breathing through the endotracheal tube.
Twelve patients (7 men, 5 women, age 78 6 15, height
167 6 10 cm, weight 66.9 6 9.8 kg) were consecutively
Abbreviations and Acronyms
cFL 5 complete flow limitation, or completely flow
limited
COPD 5 chronic obstructive pulmonary disease
EF 5 ejection fraction
FL 5 flow limitation
LHF 5 left heart failure
LV 5 left ventricular
NEP 5 negative expiratory pressure
nFL 5 not flow limited, or absence of flow limitation
pFL 5 partial flow limitation, or partially flow
limited
SpO2 5 transcutaneous pulsed oxygen saturation
Figure 1. Schematic representation of flow-volume curves in a normal subject (left) and in a patient with severe chronic obstructive
pulmonary disease (COPD) (right). The outermost curves correspond to a forced maneuver, the innermost curves to tidal breathing. In
the normal subject, the maximal expiratory envelope is way above the tidal one. In the COPD patient, maximal expiratory flows are reduced
at all lung volumes and dramatically so at low lung volumes. Tidal expiratory flow reaches the maximal expiratory flow, defining flow
limitation. As compared with normal subjects, residual volume (RV) and functional residual capacity (FRC) are shifted toward total lung
capacity (TLC), defining hyperinflation: RV in the patient approximately corresponds to FRC in the normal subject. COPD 5 chronic
obstructive pulmonary disease; FRC 5 functional residual capacity; TLC 5 total lung capacity; RV 5 residual volume.
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enrolled (Table 1, Appendix 1). At the time of the study,
which took place within the first 24 h after admission in all
cases but two (Patients #2 and #8 were studied seven and
10 days after admission, respectively), all patients were
treated with oxygen and diuretics. Other treatments are
listed in Table 1. All patients but one (Patient #12) had a
longstanding history of cardiac disease. Before the acute
LHF episode, all patients met the criteria for functional
class II or III of the New York Heart Association classifi-
cation. During the acute episode, their functional impair-
ment corresponded to class IV. The suspected etiology of
acute LHF was poorly controlled hypertension in four cases
(Patients #1, #2, #4, #11), unstable angina in three cases
(Patients #5, #6, #7) and supraventricular arrhythmia in one
case (Patient #8). No clear causative mechanism was iden-
tified in four cases (Patients #3, #7, #10, #12). To rule out
associated COPD, which could have been a confounding
factor, the patients’ charts were carefully reviewed and the
patients were reexamined after the acute LHF episode. In
no case did the clinical history or physical findings suggest
COPD (14,15). Among patients who survived the acute
episode, only two were both fit and cooperative enough to
undergo spirometric evaluation (Patients #1 and #4). In
these two cases, vital capacity was 91% and 102% of predicted
values, with no spirometric signs of airway obstruction.
Ten age-matched normal volunteers, free of chronic
cardiac or respiratory disease, served as controls (six men,
four women, age 76.7 6 8.8, 167 6 10 cm, 70.1 6 11.7 kg).
The study was conducted according to local ethical and
legal rules. The patients or next of kin were informed in
detail of the procedures by the clinician in charge and gave
written consent.
METHODS
Physiological parameters. Patients were studied while
breathing spontaneously (through a size 7.5 endotracheal
tube for two of them who had been intubated and mechan-
ically ventilated in the emergency room because of profound
hypoxemia and compromised neurological function). Air-
flow was measured with a pneumotachograph (HR 4700A;
Hans-Rudolph, Kansas City, Kansas; linearity: 6 2.6
L z s21) in series either with a rubber mouthpiece (10
patients and 10 controls) or with the tracheal tube (two
patients) and connected to a differential pressure transducer
(MP 45, 6 2 cmH20; Validyne; Northridge, California).
Volume was obtained by integration of the flow signal.
Pressure was measured at the mouth or at the airway
opening (intubated patients) using a noncompliant polyeth-
ylene tubing of 1.6 mm internal diameter, connected to a
differential pressure transducer (Validyne DP 15, 6 100
cmH2O). Calibration of all signals was performed at the
beginning and end of each session.
Orthopnea. The presence of orthopnea was assessed as
follows. While the patients were being seated, a semiquan-
titative evaluation of their perceived “difficulty in breathing”Ta
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was first performed using a modified Borg Scale (1) (Ap-
pendix 2). After the shift to the supine position, the patients
were first asked if they felt better, the same or worse. If they
answered “worse,” they were presented with the scale again
for reevaluation. Orthopnea was arbitrarily defined as onset
or worsening of dyspnea when shifting from the sitting to
the supine position. This assessment was carried out by an
investigator different from the one performing the physio-
logical measurements.
NEP. APPARATUS. A negative pressure was applied at the
mouth or airway opening throughout tidal expiration, as
follows. A Venturi device was placed in series with a
pneumotachograph (Aeromech Devices Ltd; Almonte,
Canada) (Fig. 2). When fed with compressed air, this
device created a negative pressure in the circuit, the mag-
nitude of which could be precisely regulated. The Venturi
was connected to a solenoid valve (Asco electrical valve,
model 8262G208; Ascoelectric, Canada), which was con-
trolled by a computer and automatically activated when the
expiratory flow reached a preset value. The dead space of the
equipment was 35 ml. Negative expiratory pressure
(23.5 cmH2O) was applied 0.2 s after the onset of expira-
tion and maintained throughout expiration at a level of
23.5 cmH2O. A NEP test was performed every five
respiratory cycles.
ANALYSIS. The response to NEP was analyzed in terms of
expiratory flow. In the absence of FL, NEP results in an
increase of expiratory flow and a decrease in end-expiratory
lung volume (Fig. 3). Conversely, if FL is present, the
expiratory flow is unaffected by NEP (Fig. 3) (5,16). [Flow
limitation is a term often used to indicate that, in a given
patient, the expiratory flows during a forced expiratory
maneuver are reduced below the predicted normal. In this
study, the term is used to indicate that the expiratory flow
rates achieved during the entire, or part, of the tidal
expiration are the maximum achievable under the prevailing
conditions.]
PROCEDURES. The patients were first connected to the
experimental setup and received supplemental oxygen. Im-
mediately before data acquisition, oxygen was stopped and a
nose clip applied. Since the patients were breathing room air
during the measurements period, transcutaneous oxymetry
(SpO2) was closely monitored. If SpO2 dropped below 94%,
the tests were stopped and the patient was back on oxygen.
Each run lasted less than 60 s, and interruption because of
low SpO2 was seldom necessary.
In all patients and controls, four to six NEP tests and
Figure 2. Schematic representation of the experimental setup
used. A Venturi system is placed in series with a pneumotacho-
graph and a mouthpiece, allowing measurement of flow, volume
and mouth pressure (Pm), respectively. When compressed air is
fed through the Venturi via a computer-driven valve, a negative
pressure is generated at the mouth. Its value can be adjusted using
a potentiometer. Signals are conditioned, monitored and stored on
a personal computer. Volume is obtained by numerical integration
of the flow signal. Pm 5 mouth pressure.
Figure 3. Top panel: Flow (top trace), volume (middle trace) and
mouth pressure (Pm, bottom trace) vs. time. Negative expiratory
pressure (NEP) is applied during the last expiration shown (Pm
trace). The ensuing expiratory flow is not different from that
observed during the preceding control expiration, defining flow
limitation (FL). Bottom panel: Examples of flow-volume curves
in response to NEP (arrows) with corresponding curves of
preceding control breaths. In the patient without FL (nFL, left),
the expiratory flow-volume curve with NEP is above that of the
control breathing cycle throughout expiration. In the patient with
partial FL (pFL, middle), the expiratory flow-volume curve with
NEP is superimposed on the latter part of the corresponding
control expiratory flow-volume curve. In the patient with complete
FL (cFL, right), the expiratory flow-volume curve with NEP is
superimposed on the whole control curve, except for an initial
transient increase in flow. See text for further details. cFL 5
completely flow limited; FRC 5 functional residual capacity;
NEP 5 negative expiratory pressure; nFL 5 not flow limited;
pFL 5 partially flow limited; Pm 5 mouth pressure.
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evaluations of dyspnea were performed in each of the
following conditions: 1) seated, 2) supine, first 2 min, 3)
supine, 15 min or at the limit of clinical tolerance. In four
patients, the measurements were repeated after returning to
the sitting position. Follow-up studies were conducted in
two patients several days later to examine the effects of
treatment.
Changes in functional residual capacity between the
sitting and the supine position were assessed by comparing
the corresponding inspiratory capacities. This was carried
out in all controls and attempted in all patients. Due to the
severity of the acute respiratory distress, reliable inspiratory
capacity maneuvers could be obtained in only four patients.
Data processing. Flow and pressure signals were ampli-
fied, filtered and then digitized at 200 Hz using a 16 bit
analog-to-digital converter (DIREC Physiologic Recording
System; Raytech Instruments, Vancouver, Canada) and an
IBM-compatible personal computer. All signals were sam-
pled at 200 Hz. The signals were monitored on-line and
stored on a hard disk for off-line analysis (ANADAT 5.2,
RHT-InfoDat Inc., Montreal, Canada). Negative expira-
tory pressure cycles suggestive of complete upper airway
collapse were discarded (17). Three categories of response
were defined (Fig. 3): 1) absence of FL (nFL): expiratory
flow increased throughout expiration; 2) complete FL
(cFL): NEP did not increase expiratory flow, except for a
short initial peak which corresponds to air being suddenly
sucked out of the compliant upper airways (cheeks, etc.) and
to a small artefact due to the common mode rejection ratio
of the flow transducer (5,16); 3) partial FL (pFL): flow
increased during the first part of expiration only.
Statistical analysis. Within and between groups, compar-
isons of continuous variables were performed using analysis
of variance for repeated measures and a protected least
square Fisher’s test. Flow limitation being taken as a
dichotomous variable, a chi-square test was performed to
compare patients and controls and orthopneic versus
nonorthopneic patients. Differences were considered sig-
nificant for a p value less than 0.05. Data are expressed as
mean 6 SD.
RESULTS
The two groups were not statistically different regarding
age, gender, height or weight.
Breathing pattern. In the sitting position, respiratory fre-
quency was significantly higher in patients than in controls
(29.3 6 5.9 vs. 15.4 6 5.1 breaths/min, p 5 0.0001). This
was associated with a slightly increased minute ventilation
(14.3 6 6.0 vs. 11.1 6 3.2 L z min21, p 5 0.04) despite a
lower tidal volume (483 6 174 vs. 770 6 281 ml, p 5
0.0002) (Fig. 4). Expiratory time was shorter in patients
than in controls (1.43 6 0.35 vs. 2.63 6 0.92 s; p 5
0.0001). This reduction was proportionally more important
than the reduction in tidal volume and in the total respira-
tory time; hence, in the patients there was slightly increased
mean expiratory flow (ratio of tidal volume to expiratory
time) (0.366 6 0.204 vs. 0.305 6 0.089 L z s21, p 5 0.049)
and an increased expiratory-to-total time ratio (0.662 6
0.094 vs. 0.615 6 0.053, p 5 0.0001). The mean inspiratory
flow (ratio of tidal volume to inspiratory time), which is an
index of inspiratory drive, was higher in patients than in
controls (0.715 6 0.199 vs. 0.473 6 0.137 L z s21; p 5
0.0001).
Shifting from sitting to supine position did not signifi-
cantly modify the breathing pattern in either the patients or
the controls (p 5 0.47) (Fig. 4). Since inspiratory capacity
decreased by 657 6 408 ml in controls, functional residual
capacity declined in the supine position. This was not the
case in the four patients in whom inspiratory capacity could
be measured in both positions.
FL and position. All control subjects were nFL both
sitting and supine. When sitting, eight patients were nFL,
three were pFL and one was cFL. Five of the eight patients
who were nFL sitting became partially (n 5 3) or com-
pletely (n 5 2) flow limited in the supine position. Two of
Figure 4. Average breathing cycle in the seated (solid lines) and the supine (dashed lines) position, in control subjects (left panel) and
patients with acute left heart failure (right panel). Bars represent one standard deviation (maximal standard deviation noted in each group
at each point). Between groups, differences are statistically significant, whereas between positions, they are not. E 5 expiration; I 5
inspiration.
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the three patients who were pFL when sitting became cFL
in the supine position. Thus, FL either appeared or became
more pronounced in the supine position in seven out of nine
patients (Fig. 5). It should be noted that the three patients
who were nFL both seated and supine (Patients #4, #7, #12)
were studied several hours after initiation of treatment with
diuretics and vasodilators. Flow limitation was significantly
more frequent in patients than in controls both in the sitting
(p 5 0.043) and the supine (p 5 0.003) position.
Within 15 min of returning to the seated position, the
degree of FL had reverted to the initial value in the four
patients tested (Patients #2, #8, #10, and #11; Fig. 5). The
time course of FL upon changing position was variable, but
in most cases it took several minutes for FL to appear to
disappear (Fig. 6). In some instances, FL was less when the
patient had returned for a while to the sitting position than
under baseline conditions (Fig. 6).
In Patients #6 and #11 (initially pFL in the supine
position) who were restudied after several days, orthopnea
and FL were absent both sitting and supine.
FL and orthopnea. Neither the control subjects nor the
three patients who were nFL in both seated and supine
positions reported orthopnea (Fig. 5). In contrast, the five
patients who were nFL when seated but pFL or cFL when
supine did. This was also the case of one of the two patients
who were pFL when seated and became cFL when supine.
Orthopnea occurred significantly more frequently in pa-
tients flow limited in the supine position than in not flow
limited (p 5 0.003).
DISCUSSION
The salient feature of this study is the observation of
expiratory FL in supine patients with acute LHF and
without evidence of underlying obstructive airway disease.
The aggravation of FL in the supine position suggests a
possible mechanism for acute LHF-related orthopnea. Be-
fore discussing these findings in detail, a brief description of
the NEP technique as a tool to detect FL is required.
Detection of FL. Flow limitation implies that tidal expi-
ration takes place on or above the maximum expiratory
flow-volume curve (3). It is present at rest in most patients
with severe airway obstruction although difficult to demon-
strate. Indeed, its conventional detection is complex and
time consuming. It requires the use of a body plethysmo-
graph (18) and, thus, is neither feasible nor reliable in
patients with acute respiratory failure. In addition, the
magnitude of the flow during forced expiration depends
markedly on the volume and time history of the inspiration
that immediately precedes it (19,20). Since, by definition,
volume and time history are radically different during
resting breathing and forced maneuvers, comparisons of
tidal and maximal flow-volume curves may lead to an
erroneous assessment of FL (5,21). To overcome these
Figure 5. Effects of changing position on flow limitation (FL) and orthopnea. Each patient is represented by a number and a symbol placed
in the compartment corresponding to his degree of FL. Closed symbols represent the patients reporting orthopnea, while open symbols
correspond to patients without orthopnea. cFL 5 completely flow limited; nFL 5 not flow limited; pFL 5 partially flow limited.
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technical and conceptual difficulties, Valta et al. (16) and
Koulouris et al. (5) have recently proposed a very simple
technique that can detect FL without resorting to forced
maneuvers. With this technique, a NEP is applied at the
airway opening during a single tidal expiration (Fig. 2), and
the ensuing flow-volume curve is compared with that of the
previous control expiration (Fig. 3). If NEP produces a
sustained increase in expiratory flow, there is no FL. By
contrast, if the expiratory flow does not change with NEP,
or if the change is only transient (gas decompression from
the expiratory line [5,16]), FL is present. Since NEP does
not elicit changes in respiratory muscles activity (22), an
active resistance to expiration (upper airway narrowing or
postinspiratory diaphragm activity) cannot be responsible
for the lack of change in expiratory flow. This would imply
a performance of respiratory muscles in load compensation
far beyond the range of described mechanisms (23). In
addition to being devoid of many of the drawbacks associ-
ated with other methods, the NEP technique can be applied
to noncooperative patients during acute respiratory distress
and in any position.
Expiratory FL and LHF. Pulmonary function tests in
LHF typically demonstrate a restrictive ventilatory defect
(24), and low and falling vital capacities have been reported
as predictors of heart failure in the Framingham study (25).
This is interpreted as reflecting an increase in intrathoracic
fluid and enlargement of the heart. Bronchial obstruction is
also often present in LHF (7,8). Since the early description
of bronchial mucosal swelling in LHF (26), several mech-
anisms have been implicated. These include: a) accumula-
tion of edema and foam (7,27); b) thickening of the
bronchial wall by edema and increased vascular volume,
particularly of bronchial veins (28); c) peribronchial edema
and vascular engorgement of bronchovascular sheaths (29);
d) impairment of the radial distending forces exerted on the
bronchial wall by lung elastic recoil through a loss of lung
volume (30) or hindered transmission of these forces to the
bronchial wall; such uncoupling is an important determi-
nant of lung volume related changes in bronchoconstrictor
response to methacholine (31); e) increased airway smooth
muscle contractility by humoral and neural mechanisms (7).
All the above mechanical and nonmechanical factors can
produce airway obstruction in LHF and increase the likeli-
hood of abnormal bronchial responses to otherwise trivial
stimuli (13).
Our patients had severe LHF (Appendix 1, Table 1).
They all had radiographic evidence of pulmonary alveolar or
interstitial edema (Table 1). Two patients had wheezes on
auscultation. This makes it reasonable to postulate that
airway obstruction was present and severe enough for FL to
Figure 6. Time course of the effect of postural changes on the response to negative expiratory pressure (NEP). Four left panels, in a
representative patient (#2); two right panels, in a control subject. In the patient when first studied seated, flow limitation (FL) encompasses
less than 50% of tidal volume (pFL; top panel, left). Flow limitation worsens (more than 50% of tidal volume, cFL) in supine position
(top panel, right) and diminishes when the patient returns to the sitting position (bottom panels). The degree of FL continues to decrease
for several minutes after resuming the sitting position, and after 15 min, the patient is no longer flow limited. In the control subject, there
is no FL.
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occur, particularly since the patients had an increased mean
expiratory flow (Fig. 4), which promotes FL (6). Predict-
ably, the mean inspiratory flow was also increased, probably
reflecting an increase in central respiratory drive.
The causality of LHF in tidal FL in our patients is
supported by the observations in Patients #4, #7 and #12 on
the one hand and in Patients #6 and #11 on the other hand.
The first three patients were nFL both sitting and supine,
despite a clear-cut history of LHF and a clinical presenta-
tion highly suggestive of pulmonary edema. However, in
contrast to the rest of the study population, they were
investigated several hours after the start of depletive and
vasodilator therapy. It is possible that by the time measure-
ments were made, they had sufficiently improved for FL to
have disappeared. Patients #6 and #11 were reevaluated a
few days after the onset of the acute episode, after effective
treatment and prior to discharge. In both cases, FL, which
was present in the supine position during the initial study,
was no longer observed.
Underlying COPD, if present in our patients, would have
constituted a confounding factor. However, for FL to occur
in COPD, the disease must be severe (4). Selection criteria
excluded patients with either known COPD or who were at
risk for COPD. In addition, careful chart reviews never
elicited findings suggestive of COPD. Spirometric evalua-
tion of two patients performed after the LHF episode ruled
out significant obstruction in their cases. Furthermore,
severe COPD is associated with particular clinical features
(14,15), none of which were present either at recruitment or
when reexamined after the acute LHF episode. Therefore,
we are confident that COPD severe enough to be associated
with expiratory FL was not present in our patients. Finally,
it should be noted that the absence of FL in all of our
control subjects rules out age as a possible confounding
factor.
Influence of posture on FL. Several mechanisms can be
postulated to explain the clear postural nature of FL in our
patients (Fig. 5 and 6). The first is a reduction in lung
volume in the supine position. In normal subjects, this may
amount to up to 1 L (32), but the influence of postural shifts
on lung volume is much reduced in patients with severe
airway obstruction (28,32) or LHF (33). Moreover, func-
tional residual capacity did not decrease in the supine
position in the four LHF patients in whom it could be
assessed, whereas a marked reduction was seen in the
control group (657 6 408 ml). A second mechanism that
could account for postural changes in FL is a change in
breathing pattern (e.g., increased tidal volume or decreased
expiratory time) (6). However, in our patients, tidal volume,
breathing frequency, inspiratory time, expiratory time and
mean expiratory flow were similar sitting and supine (Fig.
4). This finding is not completely unexpected. In normals,
the increases in tidal volume and mean inspiratory flow
associated with postural changes are of modest amplitude
(34). Moreover, when respiration is stimulated by CO2
rebreathing, posture no longer affects breathing pattern
(35). The absence of a postural change in breathing pattern
in our patients was, thus, probably due to their respiration
being already highly stimulated by the mechanical and
chemical changes associated with LHF. A third mechanism
could account for postural changes in FL. Changing from
sitting to the supine position is indeed associated with some
degree of lung flooding, with a shift of blood into the thorax
and an increase in extravascular lung water (36). This
enhances the bronchial response to methacholine in normals
(37), aggravates dyspnea and worsens lung function in
asthmatics (38) and causes cardiac asthma in patients with
LHF (26). The slow dynamics of FL after postural changes
(Fig. 6) support the relevance of this mechanism in our
patients (39), as does the beneficial effects of treatment
(Patients #4, #6, #7, #11, #12).
Pathogenesis of orthopnea. The increased venous return
to the lung in the supine position in commonly accepted as
a critical trigger to orthopnea. Correlations between left
ventricular end-diastolic pressure and orthopnea support
this contention (40). Several mechanisms have been pro-
posed that can link an increase in central blood volume with
orthopnea. First, the resulting augmentation in pulmonary
hydrostatic pressure may lead to increased interstitial
edema, stimulation of juxtapillary receptors and increased
vagal afferentation (41). Second, increased bronchial wall
edema in the supine position could also lead to such a
parasympathetic activation (42). Third, orthopnea may
result from a rapid increase in the load against which the
inspiratory muscles must work, a factor known to promote
dyspnea (43). The increase in intrathoracic fluid volume
should indeed decrease lung compliance (12), making the
lungs more difficult to expand. The onset or exacerbation of
FL, as observed in most of our patients (Fig. 5 and 6),
should also increase the load opposed to inspiratory muscles
(see Introduction). Flow limitation leads to dynamic hyper-
inflation through incomplete lung emptying, with the per-
sistence of an alveolar pressure above atmospheric pressure
at the end of expiration (intrinsic positive end expiratory
pressure). Such an additional load to inspiratory muscles is
capable of causing breathlessness (44) and probably more so
if the ability of the inspiratory muscles to cope with a rapidly
instituted hyperinflation has been reduced by preexisting
abnormalities (45). One should, hence, keep in mind the
fact that chronic left heart diseases impair inspiratory muscle
function (46).
We do not have evidence of worsened hyperinflation in
the supine position in our patients—this would have re-
quired the placement of an esophageal and a gastric probe to
estimate pleural pressure and expiratory muscle activity—
not feasible in patients with so severe a respiratory distress.
Nevertheless, our patients had a rapid and shallow breathing
pattern, which is typical of diseases with “stiff lung” but is
also consistently observed in patients with obstructive air-
way diseases, particularly so during acute respiratory failure.
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In this setting, the shallow respiration is interpreted as an
attempt to minimize energy expenditure during a breathing
act that has become heavily loaded (47). If there is FL,
however, the correspondingly shortened expiration offsets
the putative benefits of this strategy because it promotes
dynamic hyperinflation (6). Therefore, the conjunction of 1)
the rapid shallow breathing pattern (within increased mean
expiratory flow), and of 2) the apparition or worsening of
FL seems to us a reasonable ground to hypothesize that, in
our patients reporting orthopnea, going to the supine
position could have been associated with a rapid increase in
end-expiratory lung volume and, thus, in inspiratory load.
To sum up, our hypothesis is not that the sensation of “air
hunger” that is typical of LHF is primarily due to an
increased load imposed on the inspiratory muscles. Dyspnea
and orthopnea in LHF have complex and multifactorial
determinants. We only submit here that the sudden increase
in this load induced by the onset of FL when assuming the
supine position can contribute significantly to the worsening
of the respiratory discomfort that defines orthopnea.
Practical implications and perspectives. We are aware
that the relatively limited number of patients and their age
constitute limitations to this study, as does the heterogene-
ity of the underlying cardiac disease and that of the
mechanisms of acute LHF. During acute LHF, however, 11
out of 12 patients had predominantly systolic left ventricular
dysfunction, whereas only one (Patient #2) exhibited dia-
stolic left ventricular dysfunction according to echocardio-
graphic findings (Appendix 1). Although heterogeneous
regarding cardiac abnormalities, our study population was
homogeneous regarding clinical presentation, namely severe
respiratory distress with evidence of pulmonary edema of
cardiac origin. In spite of its limitations, our study does
confirms that severe airway obstruction can be associated
with acute LHF. It suggests that FL could be an important
determinant of orthopnea in a variety of decompensated
cardiac diseases.
From a pathophysiological point of view, it is likely that
FL is going to be associated with the most severe forms of
acute LHF. Whether and to what extent it exists in less
severe forms remains to be determined. Correlations be-
tween FL and cardiac status based on sequential NEP
measurements will be useful, particularly to understand the
dynamics of the functional and anatomical improvement of
the lung after therapeutic interventions such as diuresis. The
disappearance of FL in those of our patients who were
studied after aggressive treatment suggests that NEP might
also contribute to an improved monitoring of treatments
and, therefore, to more precise adjustments.
From a therapeutic point of view, it may be inferred from
this study that interventions aiming at reducing airway
obstruction, independent of the specific treatment of cardiac
failure, could help in rapidly relieving symptoms in acutely
ill patients. [Only integration of clinical, radiological and
functional parameters will allow an investigator to distin-
guish small airways obstructive lung disease from heart
failure as the cause of FL, but the dynamics of FL with
therapy will certainly prove useful in attributing it, a
posteriori, to heart failure.] In support of this idea, methox-
amine, an apha-1-agonist that limits the magnitude of
LHF-related bronchial hyperresponsiveness (13), has been
reported to improve the exercise capacity of LHF patients
partly by decreasing their degree of exercise dyspnea (49).
APPENDIX 1.
Summary of underlying cardiac disease and echocardiographic
assessment during acute left heart failure (LHF). (echocardio-
graphic findings listed under “E:”)
Patient #1: 77-year-old woman with a long-standing his-
tory of hypertension but no clinical history of angina. E:
anteroseptal akinesia, LV dilation-end-diastolic diameter:
63 mm, severe systolic left ventricular (LV) dysfunction
(ejection fraction [EF] 21%).
Patient #2: 86-year-old woman with a long history of
hypertension, poorly controlled by diuretics. The episode of
acute left heart failure (LHF) seemed to be related to rapidly
progressing renal failure. E: concentric symetric ventricular
hypertrophy (interventricular septum and posterior wall
thickness: 15 mm and 14 mm, respectively), normal systolic
function (EF 55%)
Patient #3: 84-year-old man with diabetes and a history of
posterolateral infarct 10 years before. E: diffuse hypokinesia
with moderately depressed systolic LV function (EF 34%).
Patient #4: 61-year-old man with hypertension. E: con-
centric symmetric LV hypertrophy (interventricular septum
and posterior wall thickness: 14 mm), anteroapical hypoki-
nesia, moderately depressed LV systolic function (EF 38%).
Patient #5: 84-year-old woman with a history of myocar-
dial infarction a few years before. E: anteroseptal akinesia,
no significant LV dilation, severe LV systolic dysfunction,
(EF 26%).
Patient #6: 83-year-old man with a history of diabetes,
hypertension and exertional angina pectoris. E: diffuse
hypokinesia, severe LV dysfunction (EF 24%).
Patient #7: 83-year-old man with a history of hypertension
and dyslipidemia. He had suffered posterior myocardial
infarction followed by a coronary artery bypass grafting 17
years before. E: marked LV dilation (end-diastolic LV
diameter: 68 mm), severe LV systolic dysfunction (EF
20%).
Patient #8: 81-year-old man with diabetes, hypertension
and chronic atrial fibrillation. E: moderate LV dilation,
moderately severe LV dysfunction (EF 40%). Rapid atrial
fibrillation was present.
Patient #9: 80-year-old woman with no particular history
of disease. E: diffuse hypokinesia, LV dilation (end-diastolic
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LV diameter: 64 mm) associated with moderate mitral
regurgitation, severe LV dysfunction (EF 28%).
Patient #10: 98-year-old woman with severe aortic steno-
sis. E: indexed aortic surface: 0.21 cm2/m2, diffuse LV
hypokinesia, severe LV dysfunction (EF 26%).
Patient #11: 79-year-old woman with a history of hyperten-
sion. E: aortic stenosis (indexed aortic surface: 0.40 cm2/m2)
with mild aortic regurgitation, moderately severe LV sys-
tolic dysfunction (EF 35%).
Patient #12: 40-year-old woman who had received chemo-
therapy for a mandibular osteosarcoma 15 months before.
E: diffuse hypokinesia, LV dilation (LV end-diastolic di-
ameter: 64 mm), severe LV systolic dysfunction (EF 18%).
APPENDIX 2
Detection of orthopnea using Borg scale
While in the sitting position, patients were first asked if they
had “difficulty in breathing” (in French, “eˆtes-vous geˆne´
pour respirer”). If they answered yes, they were presented
with the scale below and the following explanations and
instructions: “This scale is used to express the intensity of
the difficulty in breathing that you perceive. Its graduation
goes from ‘0’ which corresponds to ‘not breathless at all’ to
‘10’ which corresponds to the worst difficulty in breathing
that you ever experienced. Please indicate what of the
intermediate qualifiers corresponds best to your current
status.” After lying down, the patients were asked if they felt
the same, better or worse. If they answered ‘worse,’ they
were asked to repeat their evaluation on the Borg scale, after
Mahler (1).
10 maximal
9 extremely severe
8
7 very severe
6
5 severe
4 somewhat severe
3 moderate
2 slight
1 very slight
0 nothing at all
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